This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Korea University Research and Business Foundation, Seoul National University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,274 
1 out of 1,784 
Years Active: 2023
Title: Seung Yup Ku: Innovator in Uterine Leiomyoma Diagnosis and Treatment
Introduction
Seung Yup Ku is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning uterine leiomyoma. His innovative approach utilizes microRNA for diagnosing and treating this condition, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Seung Yup Ku holds a patent for a "Diagnostic and treatment method for endometrial cavity distorting uterine leiomyoma using microRNA." This invention relates to a method of diagnosing and treating endometrial cavity-distorting leiomyoma using microRNA. The patent includes a composition and a kit for diagnosing uterine leiomyoma, which consists of an agent capable of detecting a microRNA expression level in a biological sample. The method involves measuring the microRNA expression level in a biological sample from the subject and diagnosing the presence of uterine leiomyoma when the expression level is downregulated. Additionally, it outlines a treatment method based on the same microRNA expression level.
Career Highlights
Throughout his career, Seung Yup Ku has worked with notable institutions, including the Korea University Research and Business Foundation and Seoul National University. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.
Collaborations
Seung Yup Ku has collaborated with esteemed colleagues such as Yong-jin Kim and Yoon Young Kim. Their joint efforts have furthered research and development in the area of uterine leiomyoma, enhancing the potential for innovative treatments.
Conclusion
Seung Yup Ku's contributions to the field of medical diagnostics and treatment exemplify the impact of innovation in healthcare. His work with microRNA in diagnosing and treating uterine leiomyoma represents a significant advancement in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile